http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0248133-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e78517965279f2376588a3546ade5280
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8153c4f24b5bb392c7bec09c1a5ebd81
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
filingDate 2001-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_606cc2d9745c1ee6e7d276c09ee3dfc5
publicationDate 2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0248133-A3
titleOfInvention A process for the preparation of citalopram
abstract A process for the preparation of Citalopram comprising the transformation of a compound of formula (VII), wherein R is C1-C4 alkyl. Compound (VII) is reacted in sequence with a Grignard reagent of a 4-halo fluorobenzene and a Grignard reagent of a 3-halo-N,N-dimethylpropylamine, respectively, giving a compound of formula (V), wherein R is as defined above. (V) Is hydrolysed to a compound of formula (IV), which is converted to a 5-oxime (III) by means of hydroxylamine, submitted to cyclization and converted to the corresponding 5-cyano derivative, i.e. Citalopram.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8440822-B2
priorityDate 2000-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9819513-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9930548-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9819511-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9819512-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4136193-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393838

Total number of triples: 20.